Li, T., Wang, B., Wang, Z., Ragaz, J., Zhang, J., Sun, S., . . . Hu, X. (2015). Bevacizumab in Combination with Modified FOLFOX6 in Heavily Pretreated Patients with HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial. PLoS One.
استشهاد بنمط شيكاغوLi, Ting, et al. "Bevacizumab in Combination With Modified FOLFOX6 in Heavily Pretreated Patients With HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial." PLoS One 2015.
MLA استشهادLi, Ting, et al. "Bevacizumab in Combination With Modified FOLFOX6 in Heavily Pretreated Patients With HER2/Neu-Negative Metastatic Breast Cancer: A Phase II Clinical Trial." PLoS One 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.